(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid is a chiral, non-proteinogenic amino acid derivative. It features a biphenyl group, a tert-butoxycarbonyl (Boc) protected amino group, and a carboxylic acid terminus. The molecule contains two stereocenters with defined (2S,4R) configuration, making it a sophisticated chiral building block. This compound is a key advanced intermediate in the synthesis of Aliskiren, a direct renin inhibitor used as an antihypertensive drug for treating high blood pressure. The specific stereochemistry and the Boc-protected amino acid structure are crucial for constructing the final active pharmaceutical ingredient (API) with the required biological activity and selectivity. Its primary industrial and research application is firmly within pharmaceutical synthesis. As a specialized intermediate, it is not a general-purpose synthetic reagent. Its value lies in its precise structure designed for a specific drug synthesis pathway, distinguishing it from generic amino acid derivatives used in broader peptide chemistry or basic organic synthesis.